Search for: "Mylan Pharmaceuticals"
Results 301 - 320
of 739
Sorted by Relevance
|
Sort by Date
26 Aug 2016, 7:25 am
One potential EpiPen competitor, Teva Pharmaceuticals, failed to obtain regulatory approval, delaying their entry into the market Another competitor, Sanofi, recalled its competing epinephrine delivery device because it may be delivering in incorrect dosage. [read post]
17 May 2021, 12:45 am
Unjust enrichment of pharmaceutical company towards health insurerMenzis / AstraZeneca, District Court of The Hague 14 October 2020 (Judge Knijff, Brinkman and Aalbers) [Dutch decision here]The second half of 2020 brought a remarkable decision in a case between health insurance company Menzis and pharmaceutical company AstraZeneca. [read post]
18 Aug 2014, 2:49 am
Mylan Inst. [read post]
6 Nov 2023, 8:35 am
Mylan Pharmaceuticals Inc., No. 2022-1889 (Fed. [read post]
25 Jan 2021, 8:58 am
Mylan Pharmaceuticals. [read post]
13 Nov 2019, 9:15 am
” Similarly, the Board held in Mylan Pharmaceuticals Inc. v. [read post]
12 Sep 2018, 9:46 am
This case was originally filed in March 2016 by Galderma against Amneal Pharmaceuticals under the HatchWaxman Act, 35 U.S.C. [read post]
22 Apr 2018, 8:40 am
The process of invention may not be completed by subsequent preparation of a pharmaceutical composition. [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
7 Feb 2019, 5:36 pm
In Momenta Pharmaceuticals, Inc. v. [read post]
18 Mar 2016, 2:04 pm
Mylan Pharmaceuticals, Inc., 78 F. [read post]
7 May 2012, 3:18 pm
Four additional firms--Mylan, Tower Group, Sterling Bancorp., and Manitowoc Co. [read post]
24 Aug 2023, 9:41 am
NovartisNovartis owned a European patent (EP 0 948 320) relating to pharmaceutical compositions for sustained release of the HMG-CoA reductase inhibitor Fluvastatin. [read post]
7 May 2013, 12:27 pm
Mylan Techs. [read post]
13 Dec 2021, 6:50 am
” The piece notes that “Mylan NV’s now-shuttered West Virginia plant was warned by the FDA in 2018 for a host of quality violations, not the first time inspectors had raised concerns there. [read post]
25 Mar 2009, 12:17 pm
The Digitek recall by Actavis-- which was manufacturing these generic digoxin pill for the Bertek and UDL divisions of Mylan Pharmaceuticals -- has given rise to hundreds of lawsuits filed by patients who used Digitek. [read post]
4 Nov 2008, 6:18 am
.; Actavis US; Mylan, Inc.; Mylan Pharmaceuticals, Inc.; Mylan Laboratories, Inc.; Mylan Bertek Pharmaceuticals; and UDL Laboratories, Inc. [read post]
28 Jul 2008, 10:36 am
Both Mylan Pharmaceuticals and UDL are owned by parent company Mylan, a drug company based in Pittsburgh, Pennsylvania with a market cap of $4 billion. [read post]
25 Mar 2015, 4:42 am
Mylan stands for the proposition that “the mere act of placing a pharmaceutical product on the market, without more, cannot support a Lanham Act claim. [read post]
